Duality Biotherapeutics Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Apr '26 Apr 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Market Capitalization	28,844	26,664	-	-
Enterprise Value	25,256	22,676	-	-
Last Close Price	320.00	298.20	-	-
PS Ratio	14.00	12.94	-	-
PB Ratio	10.68	9.87	-	-
P/TBV Ratio	10.70	9.89	-	-
P/FCF Ratio	-	123.14	-	-
P/OCF Ratio	133.21	123.14	-	-
EV/Sales Ratio	12.26	11.00	-	-
EV/FCF Ratio	-	104.72	-	-
Debt / Equity Ratio	0.06	0.06	0.00	0.00
Debt / EBITDA Ratio	-	-	-	0.01
Debt / FCF Ratio	0.77	0.77	0.02	0.01
Net Debt / Equity Ratio	-1.33	-1.33	0.69	1.01
Net Debt / EBITDA Ratio	7.20	7.20	7.58	-1.53
Net Debt / FCF Ratio	-16.57	-16.57	-4.94	-1.40
Asset Turnover	0.62	0.62	1.08	-
Quick Ratio	3.51	3.51	0.48	0.50
Current Ratio	3.65	3.65	0.49	0.52
Return on Equity (ROE)	-1282.14%	-1282.14%	-	-
Return on Assets (ROA)	-9.61%	-9.61%	-6.51%	-
Return on Capital Employed (ROCE)	-16.20%	-16.20%	10.50%	-69.40%
Earnings Yield	-10.01%	-10.83%	-	-
FCF Yield	-	0.81%	-	-
Buyback Yield / Dilution	-714.45%	-714.45%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.